Sort By:
Ecopetrol Reports CVM Decision on Appeal Related to the Tender Offer
BOGOTA, Colombia, July 16, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) announces that on July 15, 2026, Ecopetrol Investimentos do Brasil ("Ecopetrol Investimentos"), a controlled company of Ecopetrol S.A., received Official Letter No. 160/2026/CVM/SRE/GER-1, through which the Brazilian Securities and Exchange Commission ("CVM") informed that its Board of Commissioners, in its ordinary session held on July 14, 2026, ruled in favor of Ecopetrol Investimentos regarding the administrative appeal filed in connection with the public tender offer for the acquisition of shares (OPAV). In its Official Letter, the CVM also states that the suspension previously imposed on the OPAV is ineffective and grants Ecopetrol Investimentos until July 22, 2026, to amend and publish the OPAV offer document, including, among other matters, the new date for the auction.Ecopetrol will continue to keep the market duly informed of any material developments related to this transaction.------------------------------------- Ecopetrol is the largest company in Colombia and one of the main integrated energy companies in the American continent, with more than 19,000 employees. In Colombia, it is responsible for more than 60% of the hydrocarbon production of most transportation, logistics, and hydrocarbon refining systems, and it holds leading positions in the petrochemicals and gas distribution segments. With the acquisition of 51.4% of ISA's shares, the company participates in energy transmission, the management of real-time systems (XM), and the Barranquilla - Cartagena coastal highway concession. At the international level, Ecopetrol has a stake in strategic basins in the American continent, with Drilling and Exploration operations in the United States (Permian basin and the Gulf of Mexico), Brazil, and Mexico, and, through ISA and its subsidiaries, Ecopetrol holds leading positions in the power transmission business in Brazil, Chile, Peru, and Bolivia, road concessions in Chile, and the telecommunications sector.This release contains statements that may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. All forward-looking statements, whether made in this release or in future filings or press releases, or orally, address matters that involve risks and uncertainties, including in respect of the Company's prospects for growth and its ongoing access to capital to fund the Company's business plan, among others. Consequently, changes in the following factors, among others, could cause actual results to differ materially from those included in the forward-looking statements: market prices of oil & gas, our exploration, and production activities, market conditions, applicable regulations, the exchange rate, the Company's competitiveness and the performance of Colombia's economy and industry, to mention a few. We do not intend and do not assume any obligation to update these forward-looking statements.For more information, please contact: Investor Relations Office Email: [email protected] Head of Corporate Communications (Colombia) Marcela Ulloa Email: [email protected] View original content to download multimedia:https://www.prnewswire.com/news-releases/ecopetrol-reports-cvm-decision-on-appeal-related-to-the-tender-offer-302827632.htmlSOURCE Ecopetrol S.A.
Genesis Energy, L.P. Declares Quarterly Distribution
Related Quotes Genesis Energy L.P. Common Units 14.43 0.15 1.03% Enter Symbols: Genesis Energy, L.P. Declares Quarterly Distribution HOUSTON, Jul. 16 /BusinessWire/ -- Genesis Energy, L.P. (NYSE:GEL) announced today that the Board of Directors of its general partner declared a quarterly cash distribution to be paid to Genesis common unit holders and Class A Convertible Preferred unit holders with respect to the second quarter of 2026. Each holder of common units will be paid a quarterly cash distribution of $0.20, or $0.80 on an annualized basis, for each common unit held of record. This distribution represents a 21.2 percent increase over the distribution declared with respect to the second quarter of 2025. Genesis also repurchased 250,000 common units at a weighted average price of $14.57 per unit, for a total of approximately $3.6 million during the second quarter of 2026. Each holder of Class A Convertible Preferred units will be paid a quarterly cash distribution of $0.9473, or $3.7892 on an annualized basis, for each preferred unit held of record. The quarterly distributions to Genesis common unit holders and Class A Convertible Preferred unit holders will be paid on Friday, August 14, 2026 to holders of record at the close of business on Friday, July 31, 2026. Genesis will announce its earnings results for the second quarter of 2026 on Thursday, August 6, 2026, before the New York Stock Exchange opens for trading. Following the announcement, the partnership will host a conference call at 9:00 a.m. CDT with analysts and investors to discuss its earnings. The call will be webcast live on the Internet and may be accessed through the "Investors" section of the partnership's website at www.genesisenergy.com. A re-play of the webcast will be available following the conference call and may be accessed approximately one hour after completion of the call. Genesis Energy, L.P. is a diversified midstream energy master limited partnership headquartered in Houston, Texas. Genesis' operations include offshore pipeline transportation, marine transportation, sulfur services and onshore facilities and transportation. Genesis' operations are primarily located in the Gulf Coast region of the United States and the Gulf of America. This press release serves as qualified notice to nominees as provided for under Treasury Regulation Section 1.1446-4(b)(4) and (d). Please note that 100 percent of Genesis Energy's distributions to foreign investors are attributable to income that is effectively connected with a United States trade or business. Accordingly, all of Genesis Energy's distributions to foreign investors are subject to federal income tax withholding at the highest applicable effective tax rate. Nominees are treated as withholding agents responsible for withholding distributions received by them on behalf of foreign investors. View source version on businesswire.com: https://www.businesswire.com/news/home/20260716052654/en/ back Private-label branded pages powered by TickerTech.com. Copyright © 2026 Ticker Technologies, All Rights Reserved. Quote data is at least 20 minutes delayed. NYMEX data is at least 30 minutes delayed. Please read other important disclaimer information.
Baker Hughes Completes Acquisition of Chart Industries
Related Quotes Baker Hughes Company 57.25 0.525 0.91% Enter Symbols: Baker Hughes Completes Acquisition of Chart Industries Represents a major milestone in Baker Hughes' ongoing portfolio management strategy to become a higher-value, leading industrialized energy solutions companyExpect $325 million in annualized cost synergies by year three after close; commercial synergy opportunities represent additional upsideChart Industries will be a third operating segment, reflecting the scale and strategic importance of its differentiated capabilities HOUSTON and LONDON, July 16, 2026 (GLOBE NEWSWIRE) -- Baker Hughes Company (NASDAQ: BKR) ("Baker Hughes" or "the Company") today announced the successful completion of its acquisition of Chart Industries, Inc. (NYSE: GTLS) ("Chart"). This strategic transaction is a major milestone in Baker Hughes' transformation into a higher-value, leading industrialized energy solutions company. The acquisition is expected to enhance Baker Hughes' ability to deliver durable earnings and cash flow, driven by an expanded industrial portfolio and enhanced recurring aftermarket services. "Chart's thermal management solutions bring complementary capabilities and aftermarket service offerings that accelerate our portfolio strategy," said Baker Hughes Chairman and Chief Executive Officer Lorenzo Simonelli. "Together, we will expand the solutions we deliver across a broader range of energy and industrial markets and create greater value for customers and shareholders. We welcome our new colleagues to Baker Hughes and look forward to working with them to deliver disciplined execution and maximize synergies as we move forward." Baker Hughes Chief Infrastructure & Performance Officer Jim Apostolides has been appointed senior vice president to lead the Chart segment. Since July 2025, Apostolides has led a seamless and effective integration program to support strategic growth and operational synergy readiness. Apostolides has more than 25 years of operational and multi-industry leadership, previously serving as senior vice president of Enterprise Operational Excellence for Baker Hughes since 2020. "Congratulations to Jim on his well-deserved appointment as segment leader," Simonelli added. "Jim's business rigor, demonstrated through decades of global supply chain experience and operational leadership of large complex facilities around the world, makes him well-suited to lead implementation of the Baker Hughes Business System within Chart. We look forward to his leadership and continued success, quickly delivering value for our customers and shareholders as one company." Chart will operate as a new reporting segment within Baker Hughes, reflecting the scale and strategic importance of its differentiated capabilities in air and gas handling, thermal management, and lifecycle services. The segment structure is intended to preserve Chart's commercial and operational focus while enabling full integration and synergy capture across Baker Hughes. Chart reported $4.3 billion in revenue for fiscal year 2025 and currently serves customers in more than 50 countries, spanning sectors including gas infrastructure, nuclear, data centers, carbon capture and storage, space, geothermal and other high-growth industrial markets. Baker Hughes has launched a comprehensive integration program, leveraging its Business System to support operational alignment. The focus is on harmonizing product and technology platforms, engineering and commercial practices, and lifecycle and digital services. Early synergy capture in supply chain, functional support, and manufacturing is a priority, with a target of $325 million in annualized cost synergies within three years. The acquisition of Chart marks a significant step in Baker Hughes' portfolio optimization and growth strategy. By streamlining non-core businesses and expanding into industrial and lifecycle-driven markets, Baker Hughes is committed to sustainable, long-term growth, improved capital efficiency, and enhanced value for shareholders. The Baker Hughes Board will continue its comprehensive evaluation, guided by progress in integration and operational execution. Baker Hughes remains committed to disciplined capital allocation, targeting a net leverage range of 1.0-1.5x within 24 months. Cautionary Statement Regarding Forward-Looking Statements This news release (and oral statements made regarding the subjects of this release) may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (each a "forward-looking statement"). All statements, other than historical facts, including statements regarding the presentation of Baker Hughes' operations in future reports and any assumptions underlying any of the foregoing, are forward-looking statements. Forward-looking statements concern future circumstances and results and other statements that are not historical facts and are sometimes identified by the words "may," "will," "should," "potential," "intend," "expect," "would," "seek," "anticipate," "estimate," "overestimate," "underestimate," "believe," "could," "project," "predict," "continue," "target," "goal," or other similar words or expressions. Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Factors that could cause actual results to differ include, but are not limited to: Baker Hughes' indebtedness, including the indebtedness Baker Hughes has incurred in connection with the transaction with Chart and the need to generate sufficient cash flows to service and repay such debt; Baker Hughes' ability to meet expectations regarding the accounting and tax treatments of the transaction with Chart; the possibility that Baker Hughes may be unable to achieve expected synergies and operating efficiencies within the expected time-frames or at all and to successfully integrate Chart's operations with those of Baker Hughes; that such integration may be more difficult, time-consuming, or costly than expected; that operating costs, customer loss, and business disruption (including, without limitation, difficulties in maintaining relationships with employees, customers, or suppliers) may be greater than expected following the transaction; the retention of certain key employees of Chart may be difficult; that Baker Hughes and Chart are subject to intense competition and increased competition is expected in the future; and general economic conditions that are less favorable than expected. Other important factors that could cause actual results to differ materially from such plans, estimates, or expectations include, among others, the risk factors identified in the "Risk Factors" section of Part I of Item 1A of Baker Hughes' Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the U.S. Securities and Exchange Commission (the "SEC") on February 5, 2026, and those set forth from time-to-time in other filings by Baker Hughes with the SEC. These documents are available through Baker Hughes' website or through the SEC's Electronic Data Gathering and Analysis Retrieval (EDGAR) system at http://www.sec.gov. Any forward-looking statements speak only as of the date of this news release. Baker Hughes does not undertake any obligation to update any forward-looking statements, whether as a result of new information or developments, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements. About Baker HughesBaker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy forward making it safer, cleaner and more efficient for people and the planet. Visit us at bakerhughes.com. For more information, please contact: Media Relations Adrienne M. Lynch+1 [email protected] Investor Relations Chase Mulvehill+1 [email protected]
CVR Energy to Release Second Quarter 2026 Earnings Results
Related Quotes Cvr Energy Inc 32.55 1.03 3.07% Enter Symbols: CVR Energy to Release Second Quarter 2026 Earnings Results SUGAR LAND, Texas, Jul. 16 /BusinessWire/ -- CVR Energy, Inc. (NYSE:CVI) plans to release its second quarter 2026 earnings results on Wednesday, July 29, after the close of trading on the New York Stock Exchange. The Company also will host a teleconference call on Thursday, July 30, at 1 p.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Energy's website at www.CVREnergy.com. For investors or analysts who want to participate during the call, the dial-in number is (800) 715-9871, conference ID 3388257. A repeat of the call can be accessed for seven days by dialing (800) 770-2030, conference ID 3388257. The webcast will be archived and available on the Investor Relations section of CVR Energy's website at www.CVREnergy.com. CVR Energy's second quarter 2026 earnings news release will be distributed via Business Wire and posted at www.CVREnergy.com. About CVR Energy, Inc. Headquartered in Sugar Land, Texas, CVR Energy is a diversified holding company primarily engaged in the petroleum refining and marketing businesses as well as in the nitrogen fertilizer manufacturing business through its interest in CVR Partners, LP. CVR Energy subsidiaries serve as the general partner and own approximately 37 percent of the common units of CVR Partners, LP. View source version on businesswire.com: https://www.businesswire.com/news/home/20260716977428/en/ back Private-label branded pages powered by TickerTech.com. Copyright © 2026 Ticker Technologies, All Rights Reserved. Quote data is at least 20 minutes delayed. NYMEX data is at least 30 minutes delayed. Please read other important disclaimer information.
CBL International Announces 1-for-13 Reverse Share Split
Related Quotes Cbl International Ltd - Class B Ordi 0.4158 0.0039 0.93% Enter Symbols: CBL International Announces 1-for-13 Reverse Share Split KUALA LUMPUR, Malaysia, July 16, 2026 (GLOBE NEWSWIRE) -- CBL International Limited ("CBL International") and its subsidiaries (collectively, the "Company," "we," "us," or "our company") (Nasdaq: BANL), an established marine fuel logistics company providing one-stop solution for vessel refueling, today announced that it intends to effect a reverse share split of its Class B ordinary shares on a 1-for-13 basis (the "Reverse Share Split"). The Company's Class B ordinary shares will begin trading on a post-split basis when the market opens on July 20, 2026. The Company's Class B ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol "BANL" with a new CUSIP number G1991X133. The Reverse Share Split has been approved by the Company's shareholders and the Company's board of directors, and is being effectuated primarily to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) relating to the maintenance of the minimum bid price per share of the Company's Class B ordinary shares. Prior to the Reverse Share Split, there are currently 14,325,327 Class B ordinary shares issued and outstanding. Upon the effectiveness of the Reverse Share Split, every thirteen (13) shares of par value of USD0.0001 each of the Company's issued and outstanding Class A ordinary shares and Class B ordinary shares as of the effective date will automatically be combined into one (1) Class A ordinary share of par value of USD0.0013 each of the Company and one (1) Class B ordinary share of par value of USD0.0013 each of the Company, respectively. Any fractional shares that would have otherwise resulted from the Reverse Share Split will be rounded up to the next whole number at the participant level and no fractional shares will be issued. The Reverse Share Split affects all shareholders uniformly and will not alter any shareholder's percentage interest in the Company's outstanding ordinary shares, except for adjustments that may result from the rounding up of fractional shares. About CBL International Limited CBL International Limited (Nasdaq: BANL) is the listing vehicle of Banle Group, a reputable marine fuel logistics company based in the Asia Pacific region that was established in 2015. We are committed to providing customers with one-stop solution for vessel refueling, which is referred to as a bunkering facilitator in the bunkering industry. We facilitate vessel refueling mainly through local physical suppliers in over 70 major ports covering Australia, Belgium, China, Hong Kong, India, Japan, Korea, Malaysia, Mauritius, Netherlands, Panama, the Philippines, Singapore, Taiwan, Thailand, Turkey, and Vietnam. While the Group's primary focus remains on its established bunkering facilitation services, it has taken a measured step to broaden its presence in the sustainable energy supply chain through the distribution of sustainable fuel materials and biofuel supply. The Group actively promotes the use of alternative fuels and holds the ISCC EU and ISCC Plus certifications, as well as an EcoVadis Silver Medal. For more information about our company, please visit our website at https://www.banle-intl.com. Forward Looking Statements Certain statements in this announcement constitute "forward-looking" statements pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may", "could", "will", "should", "would", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict", "potential", "project" or "continue" or the negative of these terms or other comparable terminology. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's financial results filings with the U.S. Securities and Exchange Commission. CONTACTS CBL International Limited Investor Relations DepartmentEmail: [email protected]
Halliburton Awarded LSTK Contracts by Aramco for Onshore Oil Re-Entry Program
Related Quotes Halliburton Company 35.065 0.185 0.53% Enter Symbols: Halliburton Awarded LSTK Contracts by Aramco for Onshore Oil Re-Entry Program HOUSTON, Jul. 16 /BusinessWire/ -- Halliburton (NYSE:HAL) was awarded lump sum turnkey (LSTK) contracts by Aramco in multiple onshore fields in the Kingdom of Saudi Arabia. The awards expand Halliburton's role in the program and demonstrate the Company's ability to grow through integrated well delivery at scale. The multi-year contracts encompass approximately 285 planned wells. Halliburton will deliver a fully integrated execution model that includes oil re-entry operations, drilling, completions, and workovers. The integrated approach supports maximum asset value through operational consistency and timely well delivery and helps advance Aramco's objectives to maintain efficiency in its onshore portfolio. "These awards mark a significant milestone for Halliburton in the Kingdom and strengthen the Company's position for future growth under the program," said Rami Yassine, president, Eastern Hemisphere, Halliburton. "The scope reflects the strength of our drilling technology and our proven ability to efficiently execute complex, highly integrated operations. The program supports close collaboration with Aramco and applies Halliburton's integrated services and technologies to deliver strong performance and lower drilling and completion costs across onshore development." The contracts include a three-year base term, with options to extend for up to two additional years. Halliburton will execute the program with a focus on safety, quality, and disciplined execution, in alignment with Aramco's operational standards. ABOUT HALLIBURTON Halliburton is one of the world's leading providers of products and services to the energy industry. Founded in 1919, we create innovative technologies, products, and services that help our customers maximize their value throughout the life cycle of an asset and advance a sustainable energy future. Visit us at www.halliburton.com; connect with us on LinkedIn, YouTube, Instagram, and Facebook. View source version on businesswire.com: https://www.businesswire.com/news/home/20260716942138/en/ back Private-label branded pages powered by TickerTech.com. Copyright © 2026 Ticker Technologies, All Rights Reserved. Quote data is at least 20 minutes delayed. NYMEX data is at least 30 minutes delayed. Please read other important disclaimer information.
BKV Corporation Announces Timing of Second Quarter 2026 Earnings Release and Conference Call Details
Related Quotes Bkv Corporation 25.715 0.085 0.33% Enter Symbols: BKV Corporation Announces Timing of Second Quarter 2026 Earnings Release and Conference Call Details DENVER, Jul. 16 /BusinessWire/ -- BKV Corporation ("BKV" or the "Company") (NYSE:BKV) today announced that it will report its second quarter 2026 operational and financial results before markets open on Thursday, August 6, 2026. Management will also host a conference call at 10:00 a.m. ET on Thursday, August 6, 2026, to review the second quarter results. Participants can access the conference call by dialing (800) 420-1459 (US) or (203) 518-9861 (international). To avoid delays, it is recommended that participants dial into the conference call 15 minutes ahead of the scheduled start time. A webcast link to the conference call will also be provided on the Company's website at https://ir.bkv.com. A replay will be available shortly after the live conference call and can be accessed on the Company's website or by dialing (844) 512-2921 (US) or (412) 317-6671 (international) and then entering the replay passcode, 11162101. The replay will be available for 30 days after the call. About BKV Corporation BKV Corporation (NYSE: BKV) is a forward-thinking, growth-driven energy company focused on the sustainable development and delivery of low-carbon energy solutions and baseload power. As the largest natural gas producer by gross operated volume in the Barnett Shale, BKV is strategically expanding an end-to-end value chain that leverages its assets in upstream production, midstream infrastructure, natural gas-fired power generation and carbon capture, utilization and storage (CCUS). Through this innovative, closed-loop approach, BKV solves customers' toughest energy challenges, meeting growing power demand and enabling sustainable growth for the future. Headquartered in Denver, Colorado, BKV is committed to driving long-term, risk adjusted shareholder value by optimizing and scaling our closed-loop energy platform for a carbon neutral future. For more information, visit the BKV website at www.bkv.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260716218798/en/ back Private-label branded pages powered by TickerTech.com. Copyright © 2026 Ticker Technologies, All Rights Reserved. Quote data is at least 20 minutes delayed. NYMEX data is at least 30 minutes delayed. Please read other important disclaimer information.
Ecopetrol announces the dates for the presentation of its second quarter 2026 results report and conference call
BOGOTÁ, Colombia, July 15, 2026 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) announces that on Monday, August 3, 2026, it plans to release its financial and operating results for the second quarter of 2026, after the market closes. On Tuesday, August 4, 2026, management plans to hold a virtual conference, with simultaneous transmission in Spanish and English at the following times:Conference10:30 a.m. Colombia Time11:30 a.m. New York TimeTo participate in the conference, please use the following link and select your preferred language for the broadcast:https://xegmenta.co/ecopetrol/registro-conferencia-de-resultados-2t-2026/Participants may ask questions via the platform once the call has begun.The earnings release, presentation, webcast, and recording of the conference call will be available on Ecopetrol's website: www.ecopetrol.com.co To ensure access, we recommend that you verify in advance that your browsers allow the webcast to operate normally and that you have the latest versions of Internet Explorer, Google Chrome, and/or Mozilla Firefox.------------------------------------- Ecopetrol is the largest company in Colombia and one of the main integrated energy companies in the American continent, with more than 19,000 employees. In Colombia, it is responsible for more than 60% of the hydrocarbon production of most transportation, logistics, and hydrocarbon refining systems, and it holds leading positions in the petrochemicals and gas distribution segments. With the acquisition of 51.4% of ISA's shares, the company participates in energy transmission, the management of real-time systems (XM), and the Barranquilla - Cartagena coastal highway concession. At the international level, Ecopetrol has a stake in strategic basins in the American continent, with Drilling and Exploration operations in the United States (Permian basin and the Gulf of Mexico), Brazil, and Mexico, and, through ISA and its subsidiaries, Ecopetrol holds leading positions in the power transmission business in Brazil, Chile, Peru, and Bolivia, road concessions in Chile, and the telecommunications sector.This release contains statements that may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. All forward-looking statements, whether made in this release or in future filings or press releases, or orally, address matters that involve risks and uncertainties, including in respect of the Company's prospects for growth and its ongoing access to capital to fund the Company's business plan, among others. Consequently, changes in the following factors, among others, could cause actual results to differ materially from those included in the forward-looking statements: market prices of oil & gas, our exploration, and production activities, market conditions, applicable regulations, the exchange rate, the Company's competitiveness and the performance of Colombia's economy and industry, to mention a few. We do not intend and do not assume any obligation to update these forward-looking statements.For more information, please contact: Investor Relations OfficeEmail: [email protected] Head of Corporate Communications (Colombia) Marcela Ulloa Email: [email protected] View original content to download multimedia:https://www.prnewswire.com/news-releases/ecopetrol-announces-the-dates-for-the-presentation-of-its-second-quarter-2026-results-report-and-conference-call-302827023.htmlSOURCE Ecopetrol S.A.
Infinity Natural Resources Appoints Timothy Dugan to Board of Directors
Related Quotes Cnx Resources Corporation 33.25 0.88 2.72% Eqt Corporation 49.25 0.56 1.12% Infinity Natural Resources Inc Class A 12.86 0.05 0.39% Enter Symbols: Infinity Natural Resources Appoints Timothy Dugan to Board of Directors MORGANTOWN, W.Va., Jul. 15 /BusinessWire/ -- Infinity Natural Resources, Inc. ("Infinity" or the "Company") (NYSE:INR) today announced the appointment of Timothy Dugan to its Board of Directors (the "Board") on July 13, 2026. Mr. Dugan brings more than four decades of leadership experience across the Appalachian energy industry, having served as a chief executive officer, chief operating officer and public company director. His background spans upstream operations, midstream infrastructure, capital allocation and strategic transactions, providing the Board with extensive operational and industry expertise. "Tim is a highly respected executive in the Appalachian energy industry, with a proven track record of building high-quality businesses, creating shareholder value and leading organizations through periods of growth and strategic transformation," said Zack Arnold, President and Chief Executive Officer of Infinity. "Having had the opportunity to work alongside Tim earlier in my career, I have seen firsthand his leadership, operational expertise and strategic judgment and look forward to working with him again. His decades of experience across our basin and thoughtful leadership will be invaluable as we continue executing our long-term strategy. We are pleased to welcome Tim to our Board." Mr. Dugan most recently served as President and Chief Executive Officer of Olympus Energy, where he led the company through its successful sale to EQT Corporation (NYSE:EQT). Previously, he served as Executive Vice President and Chief Operating Officer of CNX Resources Corporation (NYSE:CNX), where he also served as Chief Operating Officer and a director of CNX Midstream Partners LP. Over a career spanning more than 40 years, Mr. Dugan has led large-scale upstream development programs, overseen midstream infrastructure and played a key role in strategic transactions across the Appalachian Basin. Earlier in his career, he held senior operational and engineering roles at Chesapeake Energy, Equitable Production Company and Cabot Oil & Gas Corporation. Mr. Dugan holds a Bachelor of Science degree in Chemical Engineering from the University of Pittsburgh. About Infinity Infinity (NYSE:INR) is a growth oriented, independent energy company focused on the acquisition, development, production and gathering of hydrocarbons in the Appalachian Basin. Our operations are focused on the Utica Shale in eastern Ohio as well as our stacked dry gas assets in both the Marcellus and Utica Shales in southwestern Pennsylvania. View source version on businesswire.com: https://www.businesswire.com/news/home/20260715861091/en/ back Private-label branded pages powered by TickerTech.com. Copyright © 2026 Ticker Technologies, All Rights Reserved. Quote data is at least 20 minutes delayed. NYMEX data is at least 30 minutes delayed. Please read other important disclaimer information.
Antero Resources Announces Second Quarter 2026 Earnings Release Date and Conference Call
DENVER, July 15, 2026 /PRNewswire/ -- Antero Resources (NYSE: AR) ("Antero" or the "Company") today announced that the Company plans to issue its second quarter 2026 earnings release on Wednesday, July 29, 2026 after the close of trading on the New York Stock Exchange. A conference call is scheduled on Thursday, July 30, 2026 at 9:00 am MT to discuss the financial and operational results. A brief Q&A session for security analysts will immediately follow the discussion of the results. To participate in the call, dial in at 877-407-9079 (U.S.), or +1 201-493-6746 (International) and reference "Antero Resources." A telephone replay of the call will be available until Thursday, August 6, 2026 at 9:00 am MT at 877-660-6853 (U.S.) or +1 201-612-7415 (International) using the conference ID: 13758945. To access the live webcast and view the related earnings conference call presentation, visit Antero's website at www.anteroresources.com. The webcast will be archived for replay until Thursday, August 6, 2026 at 9:00 am MT.Antero Resources is an independent natural gas and natural gas liquids company engaged in the acquisition, development and production of unconventional properties located in the Appalachian Basin in West Virginia. In conjunction with its affiliate, Antero Midstream (NYSE: AM), Antero is one of the most integrated natural gas producers in the U.S. The Company's website is located at www.anteroresources.com. View original content to download multimedia:https://www.prnewswire.com/news-releases/antero-resources-announces-second-quarter-2026-earnings-release-date-and-conference-call-302826798.htmlSOURCE Antero Resources Corporation
ONEOK Declares Quarterly Dividend
Related Quotes Oneok Inc 91.03 0.87 0.95% Enter Symbols: ONEOK Declares Quarterly Dividend TULSA, Okla., July 15, 2026 (GLOBE NEWSWIRE) -- The board of directors of ONEOK, Inc. (NYSE: OKE) today declared a quarterly dividend of $1.07 per share, unchanged from the previous quarter, resulting in an annualized dividend of $4.28 per share. The dividend is payable Aug. 14, 2026, to shareholders of record at the close of business Aug. 3, 2026.--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------At ONEOK (NYSE: OKE), we deliver energy products and services vital to an advancing world. We are a leading midstream operator that provides gathering, processing, fractionation, transportation, storage and marine export services. Through our approximately 60,000-mile pipeline network, we transport the natural gas, natural gas liquids (NGLs), refined products and crude oil that help meet domestic and international energy demand, contribute to energy security and provide safe, reliable and responsible energy solutions needed today and into the future. As one of the largest integrated energy infrastructure companies in North America, ONEOK is delivering energy that makes a difference in the lives of people in the U.S. and around the world. ONEOK is an S&P 500 company headquartered in Tulsa, Oklahoma. For information about ONEOK, visit the website: www.oneok.com. For the latest news about ONEOK, find us on LinkedIn, Facebook, X and Instagram. Some of the statements contained and incorporated in this news release are forward-looking statements as defined under federal securities laws. The forward-looking statements relate to our anticipated financial performance (including projected levels of quarterly and annual dividends), liquidity, market conditions and other matters. We make these forward-looking statements in reliance on the safe harbor protections provided under federal securities laws and other applicable laws. Forward-looking statements include the items identified in the preceding paragraph, the information concerning possible or assumed future results of our operations and other statements contained or incorporated in this news release identified by words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "goal," "guidance," "intend," "may," "might," "outlook," "plan," "potential," "project," "scheduled," "should," "will," "would" and other words and terms of similar meaning. One should not place undue reliance on forward-looking statements. Known and unknown risks, uncertainties and other factors may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by forward-looking statements. Those factors may affect our operations, markets, products, services and prices. These and other risks are described in greater detail in Item 1A, Risk Factors, in our most recent Annual Report on Form 10-K and in the other filings that we make with the Securities and Exchange Commission (SEC), which are available on the SEC's website at www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Any such forward-looking statement speaks only as of the date on which such statement is made, and, other than as required under securities laws, we undertake no obligation to update publicly any forward-looking statement whether as a result of new information, subsequent events or change in circumstances, expectations or otherwise. Contacts: Investor Relations: Megan [email protected] Media Relations: Charlsey [email protected]
Helmerich & Payne, Inc. Schedules Fiscal Third Quarter 2026 Conference Call and Webcast
Related Quotes Helmerich & Payne Inc 33.39 0.35 1.04% Enter Symbols: Helmerich & Payne, Inc. Schedules Fiscal Third Quarter 2026 Conference Call and Webcast TULSA, Okla., Jul. 15 /BusinessWire/ -- Helmerich & Payne, Inc. (NYSE:HP) will host a conference call to discuss its fiscal third quarter 2026 results. President and CEO Trey Adams and Senior Vice President and CFO Todd Scruggs will lead the call. The earnings release and accompanying presentation will be available at hpinc.com. Investors can join the call via phone or audio webcast. What: Helmerich & Payne, Inc.'s Fiscal Third Quarter 2026 Earnings Release. Other material developments may also be discussed. When: 10 a.m. ET (9 a.m. CT), Thursday, August 6, 2026 Via Phone: Domestic: 800-715-9871 Conference ID: 8620792 International: 646-307-1963 Conference ID: 8620792 Via Internet: Link to the webcast: H&P's Fiscal Third Quarter Earnings Call Questions: Kris Nicol, VP of Investor Relations, [email protected] If you are unable to join the live webcast, a replay will be available for 365 days in the Investor Hub section of hpinc.com under Events & Presentations. About Helmerich & Payne, Inc. Founded in 1920, Helmerich & Payne, Inc. is committed to delivering industry leading drilling productivity and reliability. H&P operates with the highest level of integrity, safety and innovation to deliver superior results for our customers and returns for shareholders. Through its subsidiaries, the Company designs, fabricates and operates high-performance drilling rigs in conventional and unconventional plays around the world. H&P also develops and implements advanced automation, directional drilling and survey management technologies. For more information, visit hpinc.com. Helmerich & Payne uses its website as a channel of distribution for material company information. Such information is routinely posted and accessible on its investor relations website at hpinc.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260715210071/en/ back Private-label branded pages powered by TickerTech.com. Copyright © 2026 Ticker Technologies, All Rights Reserved. Quote data is at least 20 minutes delayed. NYMEX data is at least 30 minutes delayed. Please read other important disclaimer information.
NPK International Announces Second Quarter 2026 Results Conference Call and Webcast Date
Related Quotes Npk International Inc 14.405 0.095 0.66% Enter Symbols: NPK International Announces Second Quarter 2026 Results Conference Call and Webcast Date THE WOODLANDS, Texas, Jul. 15 /BusinessWire/ -- NPK International Inc. (NYSE:NPKI) ("NPK" or the "Company") today announced that it will issue second quarter 2026 results after the U.S. markets close on Wednesday, July 29, 2026. A conference call will be held the following day on Thursday, July 30, 2026, at 9:30 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of the Company's website at https://investors.npki.com/. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register, download and install any necessary audio software. Individuals can also participate by teleconference dial-in. To participate in the live teleconference: Domestic Live: 833-461-5787 International Live: 365-657-4084 Conference ID: 374 346 665 After the webcast, a replay will be available on the Company's website. ABOUT NPK INTERNATIONAL NPK International Inc. is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The Company delivers superior quality and reliability across critical infrastructure markets, including electrical power transmission, oil and gas exploration, pipeline, renewable energy, petrochemical, construction, and other industries. For more information, visit our website at www.npki.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260715137100/en/ back Private-label branded pages powered by TickerTech.com. Copyright © 2026 Ticker Technologies, All Rights Reserved. Quote data is at least 20 minutes delayed. NYMEX data is at least 30 minutes delayed. Please read other important disclaimer information.
Teekay Group Publishes 2025 Sustainability Report
Related Quotes Teekay Corporation LTD. 11.045 0.045 0.41% Teekay Tankers LTD. 72.935 0.195 0.27% Enter Symbols: Teekay Group Publishes 2025 Sustainability Report HAMILTON, Bermuda, July 15, 2026 (GLOBE NEWSWIRE) -- Teekay Corporation Ltd. (Teekay) (NYSE:TK) and Teekay Tankers Ltd. (Teekay Tankers) (NYSE:TNK) (collectively, the Teekay Group) today announced the publication of their 2025 Sustainability Report, which can be accessed on the Teekay Group's website by clicking here. About Teekay Teekay is a leading provider of international crude oil marine transportation and marine services. Teekay provides these services through its controlling ownership interest in Teekay Tankers, a leading owner and operator of mid-sized crude tankers. Teekay Tankers has a fleet of 34 double-hull tankers (including 14 Suezmax tankers, 18 Aframax / LR2 tankers and two Suezmax tanker newbuilds) and has three time chartered-in tankers. In addition, Teekay Tankers manages and operates vessels for the Australian government and Australian energy companies as part of the marine services provided by Teekay Tankers and owns a ship-to-ship transfer business that performs full-service lightering and lightering support operations in the U.S. Gulf and Caribbean. Teekay's common shares trade on the New York Stock Exchange under the symbol "TK". About Teekay Tankers Teekay Tankers has a fleet of 34 double-hull tankers (including 14 Suezmax tankers, 18 Aframax / LR2 tankers and two Suezmax tanker newbuilds), and has three time chartered-in oil tankers. Teekay Tankers' vessels are typically employed through a mix of spot tanker market trading and short- or medium-term fixed-rate time charter contracts. In addition, Teekay Tankers manages and operates vessels for the Australian Government and Australian energy companies as part of the marine services provided by the Company and owns a ship-to-ship transfer business that performs full-service lightering and lightering support operations in the U.S. Gulf and Caribbean. Teekay Tankers was formed in December 2007 by Teekay Corporation Ltd. Teekay Tankers' Class A common shares trade on the New York Stock Exchange under the symbol "TNK." For Investor Relations enquiries contact:E-mail: [email protected]: www.teekay.com Forward Looking Statements The statements in this press release that are not historical facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. These risks and uncertainties include, among others, those discussed in the Teekay Group's filings from time to time with the U.S. Securities and Exchange Commission, including in each of its Annual Reports on Form 20-F for the fiscal year ended December 31, 2025. Teekay and Teekay Tankers expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in expectations with respect thereto or any change in events, conditions, or circumstances on which any such statement is based.
Expand Energy Provides 2026 Second Quarter Earnings Conference Call Information
Related Quotes Expand Energy Corporation 87.735 0.105 0.12% Enter Symbols: Expand Energy Provides 2026 Second Quarter Earnings Conference Call Information SPRING, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- Expand Energy Corporation (NASDAQ: EXE) announced today that it will release its 2026 second quarter operational and financial results after market close on July 28, 2026. A conference call to discuss the results has been scheduled for July 29, 2026 at 9:00 a.m. EDT. Participants can view the live webcast here. Participants who would like to ask a question, can register here, and will receive the dial-in info and a unique PIN to join the call. Links to the conference call will be provided on Expand Energy's website. A replay will be available on the website following the call. About Expand EnergyExpand Energy Corporation (NASDAQ: EXE) is North America's largest natural gas producer, powered by dedicated and innovative employees focused on expanding the value of natural gas by connecting global scale to growing markets. Expand Energy's returns-driven strategy strives to create sustainable value for its stakeholders by leveraging its advantaged portfolio, financial strength and operational excellence. Expand Energy is committed to expanding America's energy reach to fuel a more affordable, reliable, lower carbon future. INVESTOR CONTACT:MEDIA CONTACT:Brittany RaifordBrooke Coe(405) 935-8870(405) [email protected] [email protected]
The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.
Issued on behalf of Conexeu Sciences Inc.Conexeu Sciences Inc. (NASDAQ: CNXU) is aiming its investigational CXU platform at the largest unclaimed frontier in injectable aesthetics: restoring real body volume at a scale today's fillers were never built to reach, a move built on the company's completed 12-month P.R.O.O.F. preclinical study.RENO, Nev., July 15, 2026 /CNW/ -- Equity Insider News Commentary â Every so often, a wave of demand in one corner of medicine spills over and creates an entirely new market next door. The GLP-1 weight-loss boom is doing exactly that. As roughly 1 in 8 U.S. adults have now used a GLP-1 medication and millions reshape their bodies, a second-order demand has appeared: restoring the natural fullness that rapid weight loss leaves behind. Boston Consulting Group projects provider revenue from GLP-1-related aesthetic care will nearly triple, from about $0.7 billion to $2.0 billion by 2030. Conexeu Sciences Inc. (NASDAQ: CNXU), a preclinical-stage biotechnology company, is aiming its investigational CXU tissue-restoration platform at precisely that opening. Key TakeawaysAn unclaimed category. Large-volume body contouring, and restoration of the breasts, hips, and buttocks, is a significant injectable aesthetics category that no product has yet claimed at scale. Conexeu is positioning CXU as a potential first mover in what it calls bioregeneration.A multi-billion-dollar backdrop. The buttock augmentation market alone is projected to expand from roughly $2.99 billion in 2023 to $11.72 billion by 2030, while breast implant and reconstruction markets together approach $6 billion by 2030.A completed proof point. Conexeu has finished its 12-month P.R.O.O.F. preclinical study evaluating CXU in a large-volume model, with detailed findings reserved for peer-reviewed publication.A GLP-1 demand driver. Post-weight-loss volume restoration is emerging as a durable tailwind, with category leaders like Galderma and Novo Nordisk publicly validating the same shift.A capital-cycle parallel. Just as the energy sector shows how a demand supercycle rewards the companies that build the right infrastructure, Conexeu is building the product layer for the aesthetics wave that GLP-1s set in motion.The Open Frontier No Injectable Has ClaimedLarge-volume restoration operates at a scale existing injectables were never built to serve. Traditional facial fillers were designed for fine lines and small-volume touch-ups, with a typical syringe holding about one-fifth of a teaspoon. Body restoration often requires hundreds of times that volume. Fat grafting is surgical and loses an estimated 30 to 70 percent of transferred volume to reabsorption, frequently requiring repeat procedures. Implants remain foreign material. So, the largest opportunity in aesthetics has also been its most stubborn: how to restore real volume with a needle instead of an operating room.Conexeu's answer is CXU, a thermosensitive, flowable collagen scaffold. It is designed to flow through a fine needle for placement, conform to three-dimensional geometry, and set in situ at body temperature, supplying a structural scaffold the body's own cells and signals can populate, so that tissue can form where the material is placed rather than being displaced by an inert filler. The company completed its 12-month P.R.O.O.F. study, short for Performance and Regeneration Outcomes of Flowable Collagen, evaluating that approach in a large-volume model. It is important to note that P.R.O.O.F. is a preclinical, animal-model milestone. It does not represent a commercial launch or regulatory clearance, and the findings have not been peer-reviewed."Large-volume body contouring is the prize no one has claimed, and it is exactly where we are aiming CXU," said Miles Harrison, President and CEO of Conexeu. "Neuromodulators, fillers, and biostimulators were each defined by a first mover, and we believe CXU can help establish a potential new category, bioregeneration, by pairing volume with tissue regeneration."What a First Mover Can DoCategory creation in aesthetics is not theoretical. BOTOX® began as a medical product and, after its 2002 aesthetic approval, defined an entirely new injectable category, neuromodulators, from a standing start. That category is now estimated at between $9 and $12 billion, and AbbVie's Botox franchise alone reached roughly $5.9 billion in fiscal 2025. Each injectable category that followed was likewise defined by a first mover. Conexeu's thesis is that large-volume bioregeneration is the next such opening. This is a category analogy, not a product comparison; CXU and BOTOX® address different needs by different mechanisms."Few existing injectables were designed to restore larger volumes and remain in place. That is a requirement problem, not a marketing problem, and it is why the category remains open," said Claudia Chavez-Munoz, MD, PhD, Chief Scientific Officer. "We are evaluating CXU against that requirement through disciplined preclinical work."The Bigger Lesson: Demand Waves Reward the BuildersInvestors who want to understand the opportunity in front of Conexeu can look to a very different corner of the market for the pattern. Across the energy sector, a demand supercycle, driven by tight refining capacity, geopolitical supply disruptions, and structural under-investment, has rewarded the companies positioned with the right assets and the discipline to execute. The specific businesses differ entirely from a preclinical biotech, but the underlying dynamic is the same one Conexeu is betting on: when a powerful, durable wave of demand arrives, the companies that built the right product or infrastructure to meet it are the ones that capture the value. The names below are illustrative market context from that capital cycle, not peers or comparables to CNXU.Valero Energy (NYSE: VLO) offers the clearest read on how quickly a demand cycle can reprice a business built to serve it. In the first quarter of 2026, Valero swung to net income of $1.3 billion, or $4.22 per share, reversing a $595 million loss a year earlier, as its refining segment generated $1.8 billion in operating income on throughput of 2.9 million barrels per day. Its renewable diesel segment turned a $141 million year-ago loss into $139 million of operating income, a reminder that the same operator can capture more than one wave at once. That is the essence of a platform thesis: build the capability, then let multiple demand streams flow through it, which is exactly the logic behind Conexeu's one-formula, one-device platform strategy.Talos Energy (NYSE: TALO) shows the leverage that a focused, high-margin operator gains by concentrating on a differentiated niche. The Gulf of America-focused independent delivered first-quarter 2026 production of roughly 89,000 barrels of oil equivalent per day, generating adjusted EBITDA of $293 million, or about $37 per barrel of oil equivalent, among the top-decile margins in its sector. It also agreed to acquire deepwater Gulf assets from Shell for $850 million to deepen that position. The takeaway relevant to Conexeu is not the offshore economics but the principle: an operator that owns a hard-to-replicate niche captures outsized value when demand arrives. Conexeu is trying to establish exactly that kind of defensible position in large-volume bioregeneration before the category exists in earnest.PBF Energy (NYSE: PBF) illustrates the other side of the same coin: execution risk during the build-out. PBF posted a first-quarter 2026 adjusted loss of $0.88 per share even as revenue rose nearly 12% year over year to $7.90 billion, weighed down by the phased restart of its Martinez refinery after a 14-month rebuild. The company is targeting $350 million in annualized savings through its Refining Business Improvement program. For a preclinical company like Conexeu, PBF is a useful reminder that even businesses positioned for a favorable cycle must still execute through operational milestones, exactly the disciplined, milestone-by-milestone path Conexeu describes for its own program.Equinor (NYSE: EQNR) rounds out the picture by showing what disciplined, long-horizon investment looks like when it pays off. The Norwegian energy major delivered record first-quarter 2026 production of 2.313 million barrels of oil equivalent per day, up 9% year over year, with adjusted operating income of $9.77 billion, while its renewable power generation grew 29%. Equinor's combination of a cash-generating core and a growing next-generation business is the mature version of the bet Conexeu is making early: fund the platform through its milestones today so it can scale across multiple markets tomorrow. Conexeu is targeting exactly that kind of expansion, from wound care and periodontal applications to facial and body tissue restoration, subject to the regulatory review still ahead.The Demand Is Not SpeculativeThe tailwind behind Conexeu's target market is already visible in the behavior of category leaders. Galderma has run Phase IV clinical work on GLP-1-related facial volume loss, and Novo Nordisk's chief executive publicly signaled interest in aesthetic and longevity medicine in June 2026. Roughly 1 in 8 U.S. adults have now used a GLP-1 medication, and many who transform their bodies look to complete that transformation with restored, natural fullness. Boston Consulting Group estimates the GLP-1 aesthetic opportunity will grow from about $0.7 billion to $2.0 billion over five years. Conexeu is positioning CXU to serve that completed-transformation demand.Consistent with its full program, Conexeu is reserving specific findings, endpoints, and implantation volumes for peer-reviewed publication so the data can be evaluated independently. These are preclinical findings, not peer-reviewed, and clinical significance has not been established. The company is advancing a predicate-based regulatory strategy for its lead candidate, targeting a 510(k) submission in the first quarter of 2027, subject to required testing, manufacturing, and documentation.CONTINUED⦠Stay ahead of the next Conexeu Sciences milestone and get the full story and updates here.About Conexeu Sciences Inc.Conexeu Sciences Inc. (NASDAQ: CNXU) is a preclinical-stage regenerative tissue platform company. Its patented bioregenerative extracellular matrix (ECM) platform, CXU, is built on a single structural principle: one formula, one device, designed to scale across multiple addressable markets, including wound care, periodontal applications, and facial and body tissue restoration, with further opportunities in 3D printing, biofabrication, and veterinary markets. The Company is advancing a predicate-based U.S. regulatory strategy with an anticipated 510(k) submission in early 2027 for its initial indication, subject to regulatory review. Miles Harrison serves as President and Chief Executive Officer.Article SourceEquity [email protected] DISCLAIMER / DISCLOSURENothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. This article is being distributed for Market Equities Limited, ("MEL"), which wholly owns and operates USA News Group. MEL has been paid a fee for Conexeu Sciences Inc. advertising and digital media from Creative Direct Marketing Group ("CDMG"). There may be 3rd parties who may have shares of Conexeu Sciences Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. MEL and its owner/operators do not own any shares of Conexeu Sciences Inc., but reserve the right to buy and sell shares of Conexeu Sciences Inc. at any time without any further notice commencing immediately and ongoing. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MEL has been reviewed and approved on behalf of Conexeu Sciences Inc. by CDMG. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.CXU and the Company's device candidates, including Ten-Minute Tissue, are investigational and have not been cleared or approved by the U.S. Food and Drug Administration or any other regulatory authority for any use. The P.R.O.O.F study is a preclinical, animal-model study; preclinical results are not necessarily predictive of results in humans, have not been peer-reviewed, and clinical significance has not been established.FORWARD-LOOKING STATEMENTS:This publication contains forward-looking statements, including statements regarding the CXU platform, Ten-Minute Tissue, and B.R.E.A.S.T.; the early-stage, preclinical nature of the company's device candidates and the inherent uncertainty of preclinical and clinical development, including the possibility that preclinical results may not be predictive of clinical outcomes and that study objectives described as met may not translate into clinical benefit, regulatory clearance, or commercial success; the investigational status of CXU, which is not cleared or approved in any jurisdiction; risks associated with the planned 510(k) submission, including that it may not be completed within the anticipated Q1 2027 timeframe or at all, and that the FDA may request additional information or determine the device is not substantially equivalent to the identified predicate; the ability to expand the platform across additional indications, each of which would require separate regulatory authorization; and the pace and degree of market adoption. Forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially. Except as required by law, the company undertakes no obligation to update any forward-looking statement. References to other companies are based on those companies' public disclosures, are provided for industry context only, and do not imply any partnership, endorsement, affiliation, or comparable performance. CXU, Ten-Minute Tissue, and B.R.E.A.S.T. are trademarks of Conexeu Sciences Inc. or its subsidiaries.  View original content to download multimedia:https://www.prnewswire.com/news-releases/the-glp-1-boom-created-a-2-billion-opening-in-aesthetics-one-preclinical-biotech-is-building-the-product-to-fill-it-302824788.htmlSOURCE Equity Insider View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2026/15/c1489.html
A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next
Related Quotes Anaptysbio Inc 62.51 7.30 10.46% Conexeu Sciences Inc 9.50 0.84 8.12% Cenovus Energy Inc 27.51 0.10 0.36% First Advantage Corporation 21.15 0.57 2.77% Marathon Petroleum Corporation 303.40 6.52 2.20% Enter Symbols: A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next Issued on behalf of Conexeu Sciences Inc. As GLP-1 medications transform millions of bodies, a new multi-billion-dollar aesthetics opportunity is opening beneath the surface, and Conexeu Sciences Inc. (NASDAQ:CNXU) is aiming its investigational CXU™ platform squarely at it RENO, Nevada, July 15, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News Commentary - The most disruptive force in medicine right now is not a device or a diagnosis. It is a class of drugs. GLP-1 medications like Ozempic® and Wegovy® have moved from diabetes management into mainstream weight loss so quickly that roughly 1 in 8 U.S. adults have now used one. And as those millions of people reshape their bodies, they are creating a second wave of demand that the aesthetics industry is only beginning to understand: the need to restore the natural fullness that rapid weight loss leaves behind. That is the opening Conexeu Sciences Inc. (Nasdaq: CNXU), a preclinical-stage biotechnology company, is building toward. Its investigational CXU™ tissue-restoration platform is being designed to do something no injectable does today: restore real, large-volume body fullness with a needle rather than an operating room. Key Takeaways A demand wave with staying power. Boston Consulting Group projects provider revenue from GLP-1-related aesthetic care will nearly triple, from about $0.7 billion to $2.0 billion by 2030.An unclaimed category. No injectable today restores large-volume body fullness at scale. Conexeu is positioning CXU™ as a potential first mover in what it calls bioregeneration.A completed milestone. Conexeu finished its 12-month P.R.O.O.F.™ preclinical study evaluating CXU™ in small and large-volume models, with detailed findings reserved for peer-reviewed publication.A platform, not a product. CXU™ is built on a single principle, one formula and one device, designed to scale across wound care, periodontal, aesthetic, and veterinary markets.A market-tested pattern. From identity verification to biotech royalties to energy, the companies that win a structural demand shift are the ones that own a scalable, trusted platform, the very model Conexeu is pursuing. The Gap No One Has Filled For decades, aesthetics has had a stubborn blind spot. Traditional facial fillers were engineered for fine lines and small-volume touch-ups, with a typical syringe holding about one-fifth of a teaspoon. Restoring body volume, the breasts, hips, and buttocks, requires hundreds of times that amount. Fat grafting is surgical and loses an estimated 30 to 70 percent of its volume to reabsorption. Implants remain foreign material. So the single largest opportunity in aesthetics has also been one of most persistent unsolved problems. The markets behind that gap are substantial. Buttock augmentation alone is projected to grow from roughly $2.99 billion in 2023 to $11.72 billion by 2030, while breast implant and reconstruction markets together approach $6 billion by 2030. The category has stayed open, in Conexeu's framing, because no product has answered the core requirement: restore real volume, and make it stay in place. Conexeu's answer is CXU™, a thermosensitive, flowable collagen scaffold designed to flow through a fine needle, conform to three-dimensional geometry, and set in place at body temperature. Rather than acting as an inert filler, it is intended to supply a structural scaffold that the body's own cells and signals can populate, so that tissue can form where the material is placed. The company completed a 12-month P.R.O.O.F.™ preclinical study, short for Performance and Regeneration Outcomes of Flowable Collagen, evaluating that approach in a large-volume model. P.R.O.O.F.™ is a preclinical, animal-model milestone; it does not represent a commercial launch or regulatory clearance, and the findings have not been peer-reviewed. "Large-volume body contouring is the prize no one has claimed, and it is exactly where we are aiming CXU™," said Miles Harrison, President and CEO of Conexeu. "Neuromodulators, fillers, and biostimulators were each defined by a first mover, and we believe CXU™ can help establish a potential new category, bioregeneration, by pairing volume with tissue regeneration." The Precedent of a First Mover Category creation in aesthetics has a clear template. BOTOX® began as a medical product and, after its 2002 aesthetic approval, defined an entirely new injectable category, neuromodulators, from nothing. That category is now estimated at $9 to $12 billion, and AbbVie's Botox franchise alone reached roughly $5.9 billion in fiscal 2025. Each injectable category that followed was likewise established by a first mover. Conexeu's thesis is that large-volume bioregeneration is the next such opening. This is a category analogy, not a product comparison; CXU™ and BOTOX® address different needs by different mechanisms. The demand underneath is not speculative. Galderma has run Phase IV clinical work on GLP-1-related facial volume loss, and Novo Nordisk's chief executive publicly signaled interest in aesthetic and longevity medicine in June 2026. Boston Consulting Group estimates the GLP-1 aesthetic opportunity will grow from about $0.7 billion to $2.0 billion over five years. Conexeu is positioning CXU™ to serve that completed-transformation demand. What Winning a Demand Shift Actually Takes Conexeu is early, preclinical, and years from any market. But the pattern it is betting on, that a durable demand shift rewards whoever owns the scalable, trusted platform beneath it, is visible across the public markets in businesses that look nothing like a biotech. The companies below are illustrative market context, not peers or comparables to CNXU. Each simply demonstrates a different piece of the platform-and-trust logic Conexeu is pursuing. First Advantage (NASDAQ:FA) is a case study in the value of trusted infrastructure. The background-screening and identity-verification company processes more than 200 million screens a year across over 200 countries, and in the first quarter of 2026 it grew revenue 8.6% year over year to $385.2 million with adjusted EBITDA of $105.3 million, a 27.3% margin. Its entire business rests on being the verified, trusted layer that other companies build hiring decisions on. Conexeu's ambition is analogous in structure: to become the trusted, evidence-backed platform, validated through disciplined preclinical work, that a new aesthetics category is built on. In both cases the moat is credibility at scale. AnaptysBio (NASDAQ:ANAB) shows how a single, well-protected platform can throw off value across multiple streams. After spinning off its drug-development arm in April 2026, AnaptysBio became a streamlined, royalty-focused business, reporting first-quarter 2026 collaboration revenue of $25.6 million with Jemperli royalties growing 44% to $24.7 million, and an operating model management describes as carrying an EBIT margin above 95%. The lesson relevant to Conexeu is the power of owning platform intellectual property outright. Conexeu holds all rights to its CXU™ platform with no royalty or licensing obligations, protected across more than 40 jurisdictions, and intends to expand that single platform across multiple indications and markets. Cenovus Energy (NYSE:CVE) demonstrates what it looks like when disciplined, long-horizon investment finally scales. The Canadian integrated energy company posted record first-quarter 2026 upstream production of 972,100 barrels of oil equivalent per day, up 19% year over year, following its MEG Energy acquisition, and generated $3.4 billion in adjusted funds flow while raising its dividend 10%. Cenovus is the mature version of a platform bet: years of investment in scalable assets converging into step-change output. Conexeu is at the opposite end of that arc, funding its platform through early milestones, but the structural logic, build one scalable base and grow production across it, is the same. Marathon Petroleum (NYSE:MPC), operator of the largest refining system in the United States, closes the loop on why timing and positioning matter. Marathon reported first-quarter 2026 adjusted earnings of $1.65 per share, beating estimates by roughly $0.90, on revenue of $34.6 billion, as its refining and marketing segment's adjusted EBITDA jumped about 182% year over year to $1.4 billion, and it authorized an additional $5 billion in buybacks. The point relevant to Conexeu is not the refining economics but the principle: the leader positioned ahead of a demand surge captures a disproportionate share of it. Conexeu is trying to claim that first-mover position in bioregeneration before the category fully exists. A Long Road, Clearly Marked None of this changes the fundamental reality that Conexeu is a preclinical-stage company whose value rests on early science and its ability to keep funding the work through a long regulatory road. Consistent with its full program, the company is reserving specific findings, endpoints, and implantation volumes for peer-reviewed publication so the data can be evaluated independently. These are preclinical findings, not peer-reviewed, and clinical significance has not been established. Conexeu is advancing a predicate-based regulatory strategy for its lead candidate, targeting a 510(k) submission in the first quarter of 2027, subject to required testing, manufacturing, and documentation. What makes the setup worth watching is the convergence: a genuinely differentiated idea, a completed preclinical milestone, a powerful and durable demand driver in the GLP-1 wave, and a platform designed to scale across more than one market. Whether that ambition becomes something more will depend on the data and on the company's ability to finance the journey ahead. CONTINUED… Stay ahead of the next Conexeu Sciences milestone and get the full story and updates here. About Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ:CNXU) is a preclinical-stage regenerative tissue platform company. Its patented bioregenerative extracellular matrix (ECM) platform, CXU™, is built on a single structural principle: one formula, one device, designed to scale across multiple addressable markets, including wound care, periodontal applications, and facial and body tissue restoration, with further opportunities in 3D printing, biofabrication, and veterinary markets. The Company is advancing a predicate-based U.S. regulatory strategy with an anticipated 510(k) submission in early 2027 for its initial indication, subject to regulatory review. Miles Harrison serves as President and Chief Executive Officer. Article Source Energy Metal [email protected] DISCLAIMER / DISCLOSURENothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. This article is being distributed for Market Equities Limited, ("MEL"), which wholly owns and operates USA News Group. MEL has been paid a fee for Conexeu Sciences Inc. advertising and digital media from Creative Direct Marketing Group ("CDMG"). There may be 3rd parties who may have shares of Conexeu Sciences Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. MEL and its owner/operators do not own any shares of Conexeu Sciences Inc., but reserve the right to buy and sell shares of Conexeu Sciences Inc. at any time without any further notice commencing immediately and ongoing. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MEL has been reviewed and approved on behalf of Conexeu Sciences Inc. by CDMG. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. CXU™ and the Company's device candidates, including Ten-Minute Tissue™, are investigational and have not been cleared or approved by the U.S. Food and Drug Administration or any other regulatory authority for any use. The P.R.O.O.F study is a preclinical, animal-model study; preclinical results are not necessarily predictive of results in humans, have not been peer-reviewed, and clinical significance has not been established. FORWARD-LOOKING STATEMENTS: This publication contains forward-looking statements, including statements regarding the CXU™ platform, Ten-Minute Tissue™, and B.R.E.A.S.T.™; the early-stage, preclinical nature of the company's device candidates and the inherent uncertainty of preclinical and clinical development, including the possibility that preclinical results may not be predictive of clinical outcomes and that study objectives described as met may not translate into clinical benefit, regulatory clearance, or commercial success; the investigational status of CXU™, which is not cleared or approved in any jurisdiction; risks associated with the planned 510(k) submission, including that it may not be completed within the anticipated Q1 2027 timeframe or at all, and that the FDA may request additional information or determine the device is not substantially equivalent to the identified predicate; the ability to expand the platform across additional indications, each of which would require separate regulatory authorization; and the pace and degree of market adoption. Forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially. Except as required by law, the company undertakes no obligation to update any forward-looking statement. References to other companies are based on those companies' public disclosures, are provided for industry context only, and do not imply any partnership, endorsement, affiliation, or comparable performance. CXU™, Ten-Minute Tissue™, and B.R.E.A.S.T.™ are trademarks of Conexeu Sciences Inc. or its subsidiaries.
Gevo Provides Business Update and Announces Progress on Business Objectives
Related Quotes Gevo Inc 1.43 0.06 4.03% Enter Symbols: Gevo Provides Business Update and Announces Progress on Business Objectives ENGLEWOOD, Colo., July 15, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, today updated its recent progress on its business objectives. During the second quarter of 2026, Gevo executed against objectives to unlock better-than-expected growth that is anticipated to meaningfully improve non-GAAP Adjusted EBITDA1 by potentially more than double its previous estimates for 2026. The company expects to benefit from, among other things, unlocking valuable new carbon pathways for our biofuels, increasing our production from debottlenecking our operations and implementing cost improvements. "We continue to deliver solid progress on recognizing greater value from our commodities, carbon business and incentives," said Chief Executive Officer Paul Bloom. "Our actions taken in the second quarter demonstrated that our carbon strategy is working to deliver increased value for our shareholders from our operating assets, while also advancing our growth objectives." Recent highlights include: Unlocking Adjusted EBITDA growth: Opened new high-value compliance carbon market opportunities with the completion of the company's Canada Clean Fuel Regulation (CFR) carbon intensity pathway for its low-carbon ethanol with carbon capture and sequestration (CCS). The company has initiated sales of CFR credits associated with volumes previously delivered to that market. We expect sales under this new pathway to be included in the company's third-quarter 2026 financial results.Notable repeat business in voluntary carbon dioxide removal (CDR) credit market with credits representing 8,500 tons of carbon dioxide equivalent retired by Nasdaq, Inc. The company was also featured in that customer's recent corporate sustainability report.Continued growth in compliance and voluntary carbon market sales is supporting returns from Gevo's "carbon arbitrage" strategy and strengthening the company's carbon business.Enabled direct purchasing of voluntary CDR credits from Gevo through the launch of www.gevocarbon.com.Targeting monetization of more than $70 million in Section 45Z tax credits during 2026 as a result of continued low-carbon ethanol and renewable natural gas (RNG) production and improvements in the carbon intensity of those products. We expect the company's financial results for the second half of the year to reflect the cash proceeds from these monetizations.Sales growth from low-carbon racing fuel blendstock for high-end motorsports and demonstration-scale sustainable aviation fuel (SAF) production, which has expanded to serve a broader customer base. This business line is expected to generate positive operating margins this year. Operational excellence and cost improvement: Debottlenecking of Gevo North Dakota to increase low-carbon ethanol production to 75 million gallons per year is underway and targeting completion in 2026. This project is on track and on budget to deliver an expected 10-15% growth in low-carbon ethanol, coproducts, CCS and associated incentives for Gevo North Dakota starting in 2027.No expected unplanned downtime in production is required for the additional capacity upon completion. Continued progress on expansion of Gevo North Dakota to produce approximately 150 million gallons per year of low-carbon ethanol. Expansion project expected to double output, carbon capture and revenue estimates from existing Gevo North Dakota segment.Engineering, permitting and initial equipment procurement for the expansion project are underway, with targeted completion in 2028 once financing is complete and construction commences.Financing of the expansion is targeted to be completed in the second half of 2026, including the previously announced arrangement with Ara Energy. Production of RNG exceeded budgeted amounts during the second quarter and is averaging approximately 106% of expected production for the year.Full operation and utilization of the development assets the company operates in partnership with Trecora Hydrocarbons, LLC in Silsbee, Texas, where the company produces its racing and specialty fuel products, converting this business activity from a cost center in 2025 to an expected profit center in 2026.Implemented cost optimization initiatives which are expected to yield corporate run-rate reductions of greater than $5 million in 2026. Continued progress on SAF: Finished FEL-3 engineering for Project Northstar with an estimated capital expense of construction of approximately $600 million (plus or minus a typical 10% uncertainty). Very favorable results from the underlying alcohol-to-jet process modules, which was within 2% of the previous FEL-2 estimate. These modules are not site-specific and we believe enable deployment in a repeatable fashion at other locations in the future.Site-specific capital expenses increased by approximately $100 million, driven by higher civil engineering requirements due to the soil type at the Gevo North Dakota location and a significant increase in estimated shipping and logistics costs for equipment. Depending on the location of future plants, these costs could be greater or less based on the specific site. Making progress to achieve the balance of SAF contracts needed to achieve FID in the second half of the year.Financeable SAF demand in the United States is growing with support from state SAF tax credits and low-carbon fuel standards. Colorado (tax credit), Hawaii (low carbon fuel standard (LCFS)), Kentucky (tax credit), Massachusetts (tax credit), Minnesota (expanded tax credit) and New Mexico (implemented LCFS) combined consume nearly 3 billion gallons of jet fuel pear year, according to data from the U.S. Energy Information Administration, and they are implementing or extending SAF credits or low carbon fuel programs this year that are expected to help increase demand for SAF in North America.The company is considering the exiting and winding down of all activities related to SAF production in Lake Preston, South Dakota to focus completely on Project Northstar (also known as ATJ-30) at Gevo North Dakota. For any wind down of activities in Lake Preston, we would expect to have significant non-cash write-downs associated with that project. We do not anticipate any further cash expenditures associated with the Lake Preston project. The company expects to report second quarter 2026 earnings on August 6. About Gevo Gevo is a diversified energy company committed to fueling America's future with cost-effective, drop-in fuels that contribute to energy security, abate carbon, and strengthen rural communities to drive economic growth. Gevo's innovative technology can be used to make a variety of renewable products, including SAF, motor fuels, chemicals, and other materials that provide U.S.-made solutions. Gevo's business model includes developing, financing, and operating production facilities that create jobs and revitalize communities. Gevo owns and operates an ethanol plant with an adjacent CCS facility and Class VI carbon-storage well. Gevo also owns and operates one of the largest dairy-based renewable natural gas (RNG) facilities in the United States, turning by-products into clean, reliable energy. Additionally, Gevo developed the world's first production facility for specialty alcohol-to-jet (ATJ) fuels and chemicals operating since 2012. Gevo is currently developing the world's first large-scale ATJ facility to be co-located at our North Dakota site. Gevo's market-driven "pay-for-performance" approach regarding carbon and other sustainability attributes helps deliver value to our local economies. Through its Verity subsidiary, Gevo provides transparency, accountability, and efficiency in tracking, measuring, and verifying various attributes throughout the supply chain. By strengthening rural economies, Gevo is working to secure a self-sufficient future and to make sure value is brought to the market. For more information, please go to www.gevo.com. Forward-Looking Statements Certain statements in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, including, without limitation, the expected carbon market and related sales; benefits related to our Canadian CFR pathway, results of the racing fuel and demonstration-scale SAF project, sales of our Section 45Z tax credits, growth from the progress at Gevo North Dakota, results of cost-optimization initiatives, the ethanol expansion project at Gevo North Dakota and expected timing of completion, ability to secure financing for our expansion projects, progress on SAF offtake agreements, growth of the SAF market in North America, our capital expenditure expectations, our business plans, our business development activities, financial projections related to our business, and other statements that are not purely statements of historical fact. These forward-looking statements are made based on the current beliefs, expectations, and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in our most recent Annual Report on Form 10-K and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo. _________________________1 Adjusted EBITDA is a non-GAAP measure calculated by adding back depreciation and amortization, allocated intercompany expenses for shared service functions, non-cash stock-based compensation, non-cash impairment charges, leadership related transition expenses, the change in fair value of derivative instruments and other non-recurring expenses to GAAP loss from operations. A reconciliation of Adjusted EBITDA to GAAP loss from operations is provided in the financial statement tables in our latest quarterly earnings release. Media Contact [email protected] Investor ContactEric FreyVice President of Finance and [email protected]
Leonardo DRS Secures Contract for More Than 50,000 Tenum Orbit Thermal Imaging Cameras
Related Quotes Leonardo Drs Inc 43.39 0.98 2.21% Enter Symbols: Leonardo DRS Secures Contract for More Than 50,000 Tenum® Orbit Thermal Imaging Cameras ARLINGTON, Va., July 15, 2026 (GLOBE NEWSWIRE) -- Leonardo DRS, Inc. (Nasdaq: DRS) announced today the company has signed a contract to supply more than 50,000 Tenum® Orbit thermal imaging cameras under a blanket purchase agreement, marking a major production milestone for the company and underscoring growing demand for advanced thermal imaging technology across emerging mission applications. The agreement positions Leonardo DRS to support high-volume customer requirements for compact, high-performance thermal imaging systems used in applications including unmanned systems and other rapidly evolving platforms. It also reflects customer confidence in the company's manufacturing capacity and ability to deliver sophisticated sensing technologies at scale. "This agreement demonstrates the strength of our thermal imaging technology and our readiness to deliver at scale," said Jerry Hathaway, senior vice president and general manager of the Leonardo DRS EO/IS business unit. "We have made strategic investments in our production capabilities so we can respond quickly and reliably to growing customer demand across a wide range of mission applications." Developed for high-volume production across multiple end uses, including drones, the Tenum® Orbit thermal imaging module is backed by Leonardo DRS investments in factory infrastructure and manufacturing capacity designed to support annual production in the hundreds of thousands of units. The Tenum® Orbit is also designed to support exportability and compliance with applicable international trade regulations, helping customers integrate advanced thermal imaging technology more efficiently across global markets. About Leonardo DRS Leonardo DRS, Inc. (Nasdaq: DRS) is at the forefront of developing transformative defense technologies using its proven agility and delivering innovative solutions for U.S. national security customers and allies worldwide. We specialize in rapidly providing high-performance, multi-domain capabilities across next-generation advanced sensing, network computing, force protection, and electric power and propulsion. Our reputation as a trusted provider is built on a continuous focus on practical innovation, delivering quality, and meeting our customers' most demanding mission requirements. For further information on our complete range of capabilities, visit www.LeonardoDRS.com. Forward-Looking Statements This communication contains statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Those statements reflect current expectations, assumptions and estimates of future performance and economic conditions. The company cautions investors that any forward-looking statements which include contract values, contract performance and our development and production of products are subject to risks and uncertainties that may cause actual results and future trends to differ materially from those matters expressed in or implied by such forward-looking statements. Leonardo DRS Investor Relations ContactSteve VatherSenior Vice President, Corporate Development (M&A) and Investor Relations+1 703 409 [email protected] Leonardo DRS Media ContactCarrie RobinsonVice President, Marketing and Corporate Communications+1 321 266 [email protected]
Kinder Morgan Announces Second Quarter 26 Earnings Webcast
Related Quotes Kinder Morgan Inc 32.195 0.345 1.06% Enter Symbols: Kinder Morgan Announces Second Quarter 26 Earnings Webcast HOUSTON, Jul. 15 /BusinessWire/ -- Kinder Morgan, Inc. (NYSE:KMI) today announced it will release second quarter 2026 earnings results on Wednesday, July 22, 2026, after market close and will hold a live webcast and conference call. What: Kinder Morgan Second Quarter `26 Earnings Results Webcast When: July 22, 2026, at 3:30 p.m. CT, 4:30 p.m. ET Where: http://ir.kindermorgan.com/presentations-webcasts How: Live over the Internet by logging on to the web at the above address, or by phone (listen-only) by dialing 1-517-308-9019 and entering the passcode 1996386. If you are unable to listen during the live webcast, the call will be archived at www.kindermorgan.com. A recording of the conference call will also be available for replay one hour after the call until the end of the day on August 23, 2026. To access the replay, please dial 1-203-369-0166 and enter passcode 36707. About Kinder Morgan, Inc. Kinder Morgan, Inc. (NYSE: KMI) is one of the largest energy infrastructure companies in North America. Access to reliable, affordable energy is a critical component for improving lives around the world. We are committed to providing energy transportation and storage services in a safe, efficient, and environmentally responsible manner for the benefit of the people, communities, and businesses we serve. We own an interest in or operate approximately 78,000 miles of pipelines, 136 terminals, more than 700 Bcf of working natural gas storage capacity, and have renewable natural gas generation capacity of approximately 6.9 Bcf per year of gross production. Our pipelines transport natural gas, refined petroleum products, crude oil, condensate, CO2, renewable fuels and other products, and our terminals store and handle various commodities including gasoline, diesel fuel, jet fuel, chemicals, metals, petroleum coke, and ethanol and other renewable fuels and feedstocks. Learn more about our work advancing energy solutions on the lower carbon initiatives page at www.kindermorgan.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260715834596/en/ back Private-label branded pages powered by TickerTech.com. Copyright © 2026 Ticker Technologies, All Rights Reserved. Quote data is at least 20 minutes delayed. NYMEX data is at least 30 minutes delayed. Please read other important disclaimer information.